Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDPrime Medicine Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 8 | -$0.29 | -$0.23 | -$0.25 |
| Q2 2026 | 7 | -$0.29 | -$0.19 | -$0.23 |
| Q3 2026 | 3 | -$0.67 | $0.00 | -$0.24 |
| Q4 2026 | 3 | -$0.67 | $0.00 | -$0.24 |
| Q1 2027 | 3 | -$0.54 | $0.00 | -$0.19 |
| Q2 2027 | 2 | -$0.54 | $0.00 | -$0.19 |
| Q3 2027 | 2 | -$0.54 | $0.00 | -$0.19 |
| Q4 2027 | 2 | -$0.54 | $0.00 | -$0.19 |
| Q1 2028 | 3 | -$0.55 | $0.00 | -$0.19 |
| Q2 2028 | 6 | -$0.55 | $0.00 | -$0.19 |
| Q3 2028 | 5 | -$0.55 | $0.00 | -$0.19 |
| Q4 2028 | 5 | -$0.55 | $0.00 | -$0.19 |
Prime Medicine Inc Earnings Date And Information
Prime Medicine Inc last posted its earnings results on Tuesday, March 3rd, 2026. The company reported $-0.22 earnings per share for the quarter, topping analysts' consensus estimates of $-0.25 by $0.03. The company had revenue of 838.00 K for the quarter and had revenue of 4.63 M for the year. Prime Medicine Inc has generated $-1 earnings per share over the last year ($-1.35 diluted earnings per share) and currently has a price-to-earnings ratio of -2.55. Prime Medicine Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Prime Medicine Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/03/2026 | Q4 2025 | -$0.25 | -$0.26 | -0.01 | $1.29 M | $838.00 K |
| 11/07/2025 | Q3 2025 | -$0.28 | -$0.32 | -0.04 | $2.58 M | $1.23 M |
| 08/07/2025 | Q2 2025 | -$0.36 | -$0.41 | -0.05 | $4.18 M | $1.12 M |
| 05/08/2025 | Q1 2025 | -$0.32 | -$0.40 | -0.08 | $4.53 M | $1.45 M |
| 02/28/2025 | Q4 2024 | -$0.37 | -$0.36 | 0.01 | $11.92 M | $2.18 M |
| 11/12/2024 | Q3 2024 | -$0.43 | -$0.44 | -0.01 | $7.09 M | $209.00 K |
| 08/08/2024 | Q2 2024 | -$0.40 | -$0.46 | -0.06 | $1.63 M | $0 |
| 05/10/2024 | Q1 2024 | -$0.45 | -$0.44 | 0.01 | $1.92 M | $591.00 K |
| 03/01/2024 | Q4 2023 | -$0.48 | -$0.67 | -0.19 | N/A | $0 |
| 11/03/2023 | Q3 2023 | -$0.45 | -$0.55 | -0.1 | N/A | $0 |
| 08/07/2023 | Q2 2023 | -$0.42 | -$0.47 | -0.05 | N/A | $0 |
| 05/11/2023 | Q1 2023 | -$0.42 | -$0.44 | -0.02 | N/A | $0 |
| 03/09/2023 | Q4 2022 | -$0.65 | -$0.42 | 0.23 | N/A | $0 |
| 11/14/2022 | Q3 2022 | N/A | -$0.37 | N/A | N/A | $0 |
| 06/30/2022 | Q2 2022 | N/A | -$0.37 | N/A | N/A | $0 |
| 03/31/2022 | Q1 2022 | N/A | -$0.31 | N/A | N/A | $0 |
| 12/31/2021 | Q4 2021 | N/A | -$0.72 | N/A | N/A | $0 |
| 09/30/2021 | Q3 2021 | N/A | -$0.24 | N/A | N/A | $0 |
| 06/30/2021 | Q2 2021 | N/A | -$0.04 | N/A | N/A | $0 |
| 03/31/2021 | Q1 2021 | N/A | -$0.92 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Prime Medicine Inc Earnings: FAQ's
In the previous quarter, Prime Medicine Inc (:PRME) reported $-0.22 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.25 by $0.03.
The conference call for Prime Medicine Inc's latest earnings report can be listened to online.
The conference call transcript for Prime Medicine Inc's latest earnings report can be read online.
Prime Medicine Inc (:PRME) has a recorded annual revenue of $4.63 M.
Prime Medicine Inc (:PRME) has a recorded net income of $-201,142,000.Prime Medicine Inc has generated $-1.35 earnings per share over the last four quarters.
Prime Medicine Inc (:PRME) has a price-to-earnings ratio of -2.55 and price/earnings-to-growth ratio is -0.12.